Oral contraception.
The decision to prescribe Gveza should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Gveza compares with other combined hormonal contraceptives (CHCs) (see Contraindications and Precautions).